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Recent studies have questioned the accepted dogma
that the regenerative capacity of the heart following
injury is limited. Several apparently distinct popula-
tions of resident cardiac progenitor cells may have
the potential to regenerate functional heart muscle.
Despite this progress, the physiologic role and thera-
peutic potential of cardiac resident progenitor cells
remain unclear.
Cardiac myocyte cell loss related to myocardial infarc-
tion is the most common cause of congestive heart fail-
ure in the United States (Braunwald, 1997). Heart failure
is the most common diagnosis of hospitalized patients
in the United States, and the prevalence is increasing
as the population ages. While advances in the preven-
tion and treatment of atherosclerotic heart disease
have reduced cardiovascular morbidity, once damage
to the heart has occurred present therapies rarely result
in long-term improvement of cardiac function (Jessup
and Brozena, 2003). Despite the application of new
medical therapies, the prognosis of patients diagnosed
with heart failure is comparable to patients diagnosed
with many forms of cancer. Usually, inexorable decline
ensues from the time of diagnosis. Amidst the present
era of regenerative medicine and excitement regarding
stem cell therapies, attention has focused on the possi-
bility of re-growing heart muscle in order to treat
cardiac failure (Chien, 2004).
The task of inducing tissue repair of the myocardium
is fraught with obstacles. Conventional teaching sug-
gests that cardiac myocytes exit the cell cycle after a
terminal round of cell division shortly after birth. The
postnatal heart is thought to grow and adapt primarily
via cardiac myocyte hypertrophy (growth of individual
cells) as opposed to myocyte hyperplasia (an increase
in cell number). In skeletal muscle, specific myogenic
transcription factors have been identified with the ca-
pacity to drive nonmuscle cells to become skeletal
muscle myocytes (for review see Buckingham, 2001)
and resident myoblast progenitors serve as a reposi-
tory for skeletal muscle regeneration in response to tis-
sue injury. By contrast, the cardiomyogenic program
has not been clearly elucidated. For this reason it has
been difficult to unambiguously identify or isolate
cardiac progenitors during development or in the intact
heart. Prior to recent reports (discussed below) it was
not believed that cardiac progenitors, or cardioblasts,
existed in the postnatal heart.
Several approaches have been investigated to regen-*Correspondence: epsteinj@mail.med.upenn.eduerate or repair damaged hearts. Embryonic stem cells
possess the capacity to differentiate into cardiac myo-
cytes (in addition to multiple other cell lineages) that
resemble fetal or embryonic cardiac myocytes with
poorly organized sarcomeric structures. ES cell-derived
cardiac myocytes flux calcium, have spontaneous ac-
tion potentials, and spontaneously contract and will
engraft and electrically and mechanically couple to
host cardiac myocytes when transplanted into the heart
(Kehat et al., 2004). However, attempts to utilize embry-
onic stem cells to regenerate functioning heart muscle
in vivo have been complicated by ethical concerns and
the disturbing possibilities of teratoma formation and
potentially fatal cardiac arrhythmias (Couzin and Vo-
gel, 2004).
Nevertheless, the possibility that the heart can be re-
paired is not so far fetched. Zebrafish hearts will regen-
erate functioning myocardium when injured (Poss et al.,
2002). Like the amphibian limb, the zebrafish heart ap-
pears to regenerate by forming a blastema at the site
of injury where de-differentiation of cardiac myocytes
produces proliferative myoblasts. However, no similar
response to injury has been observed in mammalian
hearts. Perhaps the ability to regenerate tissue in sev-
eral organs, including the heart, has been lost or dimin-
ished through evolution in parallel with the emergence
of increased complexity of patterning and function. If
so, defining the molecular basis of cardiac regeneration
in amphibian species may provide fundamental insights
into cardiac myocyte regeneration.
But is the adult mammalian heart completely unable
to regenerate cardiac muscle? Several recent reports
raise hope that cardiac progenitor cells exist within the
adult heart. Recent work from the laboratory of Ken-
neth Chien takes advantage of a new paradigm emerg-
ing from the study of developmental cardiology to iden-
tify a population of undifferentiated cells that reside
within the mature heart (Laugwitz et al., 2005). If these
observations bear fruit, they will serve as an important
example of how a detailed understanding of organo-
genesis can inform regenerative medicine.
Until recently, the heart was believed to arise from
bilateral clusters of mesoderm that include cardiac pro-
genitors identified by coexpression of several early car-
diogenic transcription factors including Nkx2-5 and
GATA4. Within the past few years, several lines of evi-
dence have led to a surprising shift in the established
paradigm regarding the origin of cardiac myocytes. A
second population of cardiac progenitors is now recog-
nized that migrates into the outflow region of the
looped heart and provides mature cardiomyocytes that
contribute to the right ventricle and probably to the at-
ria and left ventricle as well (Cai et al., 2003; Kelly et al.,
2001; Kelly and Buckingham, 2002; Waldo et al., 2001).
This previously unrecognized population of cells is
called the secondary or anterior heart field. Precursors
of the secondary heart field probably arise in or close
to the cardiac crescent, where primary heart field cells
also arise and subsequently migrate to the anterior
pharynx before later contributing to the heart (see Fig-
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tFigure 1. The Secondary Heart Field
aIslet-1-expressing myocardial resident precursor cells are thought
pto arise from the secondary heart field (green) that originates near
ithe cardiac crescent (upper left, E7.5, red). Secondary heart field
cells then migrate to the anterior pharynx (right) and infiltrate the t
rostral and caudal poles of the heart to give rise to myocardial cells f
of the right ventricle (RV, bottom left) with contributions to the right
atrium (RA), left atrium (LA), and left ventricle (LV). Myoblasts and
tmyocardial cells of the primary heart field are shown in red.
p
b
ture 1). Secondary heart field myoblasts express many
aof the same cardiac markers as those previously
sanalyzed in the primary heart field, including Nkx2-5
oand GATA4, but they remain undifferentiated until later
1in development and they express some additional
dmarkers.
tSylvia Evans and coworkers showed that a subpopu-
tlation of cells in the anterior pharynx expresses the ho-
tmeobox gene islet-1 (isl1) (Cai et al., 2003). Expression
mof isl1 is lost when these cells differentiate into cardiac
amyocytes. Interestingly, some isl1+ cells can be iden-
utified in the mature hearts of newborn rodents and hu-
mans where they remain undifferentiated (Laugwitz et
oal., 2005). They are found most commonly in the outflow
(tract, the atria, and the right ventricle, in agreement with
bthe embryonic contribution of the secondary heart field.
aUnlike some other putative resident cardiac progenitor
cpopulations (see below), these cells fail to express stem
ccell antigen 1 (Sca-1), CD31, or c-kit, though they do
1express Nkx2-5 and GATA4. Importantly, Chien and co-
iworkers have shown that these cells can differentiate
tinto cardiac myocytes both in vivo, using an inducible
lcre-lox system, and in vitro. Isl1+ cells from hearts can
(be expanded in culture. Co-culture with cardiac myo-
acytes leads to expression of terminal differentiation
markers and electrophysiologic characteristics of fully cifferentiated cardiac myocytes including responsive-
ess to β-adrenergic agonists.
However, a number of questions remain to be ad-
ressed before the therapeutic potential of this popula-
ion can be assessed. Isl1+ cells have been isolated
nly from very young animal and human specimens,
nd the number of progenitor cells falls rapidly over the
irst few weeks of life. Do any resident progenitors per-
ist into adulthood? Most of the ex vivo studies were
erformed on cells taken from 1- to 5-day-old animals,
here only 500–600 isl1+ cells were identified per rat
eart. The rare isl1+ cells identified at later times were
ot evaluated for their ability to expand or differentiate.
mportantly, isl1+ cells were identified in multiple organ-
sms including humans, but the single human sample
xamined beyond 8 days of age (at 148 days) failed to
eveal any isl1 progenitors.
The factors that influence the ability to expand and
ifferentiate these resident progenitors need to be elu-
idated. Are these cells multipotential? Although a high
ercentage (25%) of cultured cells expressed troponin
under differentiation conditions, only 2.3% displayed
alcium transients characteristic of cardiac myocytes. A
learer understanding of the cell surface and secreted
actors provided by co-cultured myocytes will allow for
nhanced efficiency of cardiomyocyte differentiation. Can
hese factors be identified and/or enriched obviating
he need for co-culture? Questions of multipotentiality,
nd the degree to which significant and meaningful ex-
ansion is possible, including expansion from a single
solated cell, will need to be addressed, especially given
he potential concerns regarding tumor and teratoma
ormation that will accompany clinical trials.
Isl1+ cells are not the only resident cardiac progeni-
ors that may reside within the mammalian heart. A
opulation of cells with stem cell-like properties has
een identified in bone marrow, muscle, and skin by
he ability to exclude Hoechst dye, resulting in a char-
cteristic appearance after fluorescence-activated cell
orting (FACS) that led to the name “side population”
r SP to describe this pool of cells (Gussoni et al.,
999). SP cells are multipotent with limited capacity to
ifferentiate into striated skeletal myoblasts. Cells with
he ability to efflux Hoechst dye have been identified in
he heart (Martin et al., 2004). These cells are rare, and
heir ability to differentiate into contracting cardiac
yocytes or to contribute to functional repair of dam-
ged heart muscle has not yet been extensively eval-
ated.
Piero Anversa and colleagues reported the discovery
f a distinct resident population of cardiac stem cells
Beltrami et al., 2003). These cells are negative for
lood lineage markers CD34, CD45, CD20, CD45RO,
nd CD8 (Lin−) and positive for c-kit (c-kitPOS), the re-
eptor for stem cell factor (SCF). In the adult rat myo-
ardium, Lin− c-kitPOS cells are relatively rare (w1 per
04 myocytes) but more prevalent than the isl1+ progen-
tors described above. The cells are roughly one-tenth
he size of cardiac myocytes. Cardiac c-kitPOS cells iso-
ated by FACS sorting are heterogeneous with rare
7%–10%) cells expressing Nkx2-5, GATA4, and Mef2,
nd fewer still (0.5%) expressing genes encoding sar-
omeric proteins. These cells retain these characteris-
Minireview
297Table 1. Properties of Resident Populations of Cardiac Progenitors and Stem Cells
Differentiation Differentiated Self- Regenerative
Cells Markers n Method Phenotype Clonogenic Renewal Multi-Potent Capacity
lslet1+ (+) isl1, Nkx2.5, 500–600a Co-culture + GATA4, Nkx2.5 ND Yes No? TBD
Progenitors GATA4 with neonatal + sarcomeric proteins
(−) Sca-1, c-kit cardiocytes + striations/contraction
(−) sarcomeric + E-M coupling
proteins + CaH transients
+ action potential
Lin~ c-kit+ (+) c-kit w1 per Differentiation + GATA4, Nkx2.5, MEF2b Yes Yes Yes Yese
stem cells (±) GATA4, Nkx2.5, 1 × 104 medium (MEM + sarcomeric proteins (cardiocytes
MEF2 myocytes + 10% FCS + smooth muscle proteins smooth
(−) CD34, CD45, Lin 10−8 M dexa- endothelial proteins muscle,
skeletal markers, methasone) − striations/contraction endothelial
smooth muscle − sarcomeres cells)
markers
low-level sarcomeric
proteins detected
Sca-l+ stem (+) Sca-l, SPc, ND 5-aza- + GATA4, Nkx2.5, MEF2 ND Yes? ND TBDf
cells GATA4, MEF2 cytidine + sarcomeric proteinsd
(−) c-kit, CD34, − striations/contraction
CD45, Lin, Nkx2.5 − sarcomeres
(−) sarcomeric
proteins
a 500 – 600 isl1+ cells were isolated from postnatal day 5 rat heart (Laugwitz et al., 2005).
b These markers were observed in 7%–10% of cells (Beltrami et al., 2003).
c A small percentage of Sca-l+ cells effluxed Hoechst dye (Oh et al., 2003).
d <5% of cells expressed cTnI (Oh et al., 2003).
e Bands of regenerating myocardium were observed in injured hearts following intracardiac injection (Beltrami et al., 2003).
f Engraftment of Sca-1+ cells was observed in injured hearts following i.v. injection (Oh et al., 2003).
ND, not determined. TBD, to be determined.tics with passage in culture and can be expanded.
When placed in differentiation medium, c-kitPOS clones
differentiate into cells that biochemically (but not phe-
notypically) resemble cardiac myocytes. Sarcomeres or
striations and/or contractile activity are not observed.
Moreover, c-kitPOS clones also differentiate into smooth
muscle cells and endothelial cells, strongly suggesting
that they are multipotent. Of note, a common precursor
or stem cell giving rise to these three cell lineages has
not been identified previously.
Clinically relevant definitions of stem cells include the
capacity to functionally repopulate appropriate tissues
of a damaged recipient (Lakshmipathy and Verfaillie,
2005). Anversa and colleagues injected labeled c-kitPOS
cells into the border zone of hearts of syngeneic rats
after experimental myocardial infarction (Beltrami et al.,
2003). A band of labeled regenerating myocardium was
observed in 19 of 20 treated infarcts. The labeled cells
expressing sarcomeric proteins were small relative to
mature cardiac myocytes, but these cells exhibited visi-
ble striations and expressed connexin-43, a component
of the fascia adherens of intercalated discs. An in-
crease in capillary and arteriole density, and contribu-
tion of labeled cells to blood vessels, was also observed,
as was a marked improvement in multiple indices of
cardiac performance. Cardiac remodeling with improve-
ment in systolic and diastolic indices may occur via
multiple mechanisms, some of which are not dependent
on replenishing cardiac myocyte reserve. Alteration of
scar formation and remodeling, induction of angiogen-
esis, and inhibition of myocyte apoptosis are other po-
tential mechanisms. In humans, significant myocardial
regeneration is not observed following myocardial in-
farction, suggesting that if c-kitPOS cardiac stem cellsexist they are either nonresponsive or inhibited from mi-
grating and differentiating in response to acute myocar-
dial infarction. Alternatively, perhaps the resident pop-
ulation of cardiac stem cells becomes senescent over
time as most myocardial infarctions occur in older pa-
tients.
Schneider and colleagues reported a resident pop-
ulation of cardiac progenitor cells that copurifies with
the nonmyocyte fraction and is characterized by ex-
pression of stem cell antigen 1 (Sca-1+) (Oh et al., 2003).
These cells express telomerase reverse transcriptase
that has been associated with self-renewal potential
and appear to be distinct from the isl1+ and c-kitPOS
cells described above. While they do express the early
cardiac markers GATA4, Mef2, and Tef1, they do not
express Nkx2-5 or genes encoding cardiac sarcomeric
proteins. Though these cells do not spontaneously dif-
ferentiate in vitro, when exposed to the cytosine analog
5-azacytidine, a small subpopulation of cells (<5%) de-
monstrate biochemical evidence of cardiac myocyte dif-
ferentiation expressing sarcomeric α-actin, cardiac tro-
ponin I (cTnI) Nkx2-5, α- and β-myosin heavy chain, and
type 1A receptor for bone morphogenic proteins. It re-
mains unclear whether the cells that adopt some charac-
teristics of cardiac differentiation represent a homoge-
nous or (more likely) heterogeneous population of cells.
Clearly, the majority of cells do not differentiate into
cardiac progenitors under the conditions tested, raising
the question of what othercell fates, if any, were in-
duced following prolonged exposure to 5-azacytidine.
Nevertheless, in a proof-of-concept experiment, the
capacity of cardiac Sca-1+ cells to home to the heart
and engraft following intravenous injection was tested
in mice subjected to ischemia-reperfusion injury (Oh et
Cell
298al., 2003). Remarkably, labeled Sca-1+ cells were iden- i
tified in the infarct border zone two weeks following t
injury. These cells expressed sarcomeric α-actin, cTnI, s
and connexin-43, suggesting that they underwent dif- t
ferentiation into cardiac myocytes in vivo. However, t
control experiments revealed that there was evidence m
of fusion between the Sca-1+ cells and host cardiac t
myocytes (in up to 50% of the cells), a finding relevant t
to the interpretation of the experiments performed with p
c-kitPOS cells (Beltrami et al., 2003). Further studies will s
be required to determine whether a subpopulation of s
cardiac Sca-1+ cells exists with restricted developmen- p
tal potential to differentiate (at high frequency) into i
cardiac progenitors or cardiac myocytes. i
As described in Table 1, the resident population of D
isl1+ cardiac progenitors described by Chien and col- g
leagues differs fundamentally from SP cells, from the a
c-kitPOS cardiac stem cells, and from the cardiac Sca- m
1+ progenitors. The resident population of isl1+ cells in
the heart probably represents specified cardiac pro-
genitors or “cardioblasts.” By contrast, GATA4 and S
Nkx2-5 are expressed by only 7%–10% of the resident
Bpopulation of Lin− c-kitPOS cells, suggesting that this is
ma mixed population that includes both stem cells and
(
determined cardiac progenitors. Similarly, the resident
Bpopulation of Sca-1+, Lin− cells described by Schneider
Band colleagues most likely represents a heterogeneous
Cpopulation including a resident stem cell population.
aIt remains to be determined whether isl1+ cells exist
Cin the adult heart beyond the early postnatal period. In
Ccontrast, small clusters of Lin− c-kitPOS cells are ob-
Fserved in the adult in multiple species including hu-
Gmans. Similarly, in murine species a resident population
Mof Sca-1+ cells is easily identifiable in the myocardium.
3
Though each of these cell populations has the potential
Jfor self-renewal ex vivo, only the isl1+ cardiac progeni-
2
tors have thus far been induced to differentiate at high
K
frequency and to assume the phenotypic characteris- G
tics and physiological profile of cardiac myocytes as N
evidenced by (1) expression of early and late markers K
of the cardiac muscle cell lineage (and absence of 2
markers for other cell lineages), (2) formation of orga- K
nized sarcomeres, (3) spontaneous contraction includ- 4
ing chronotropic responsiveness to adrenergic stimula- L
tion, and (4) spontaneous calcium flux and cardiac L
action potentials. However, the capacity of isl1+ cardiac S
progenitors to engraft in the heart and to regenerate 6
myocardium, to electrically couple, and to contribute to M
scardiac work has not been tested.
(These are early days in the field of cardiac regenera-
Otion. Excitement regarding the possibility that bone
Mmarrow-derived stem cells or mesenchymal stem cells
ecould differentiate into cardiac myocytes has rapidly
Pled to clinical trials (Couzin and Vogel, 2004). More re-
2cently, the ability of hematopoetic and mesenchymal
Wstem cells to differentiate into cardiac myocytes has
Pbeen challenged. Before putative resident cardiac stem
Wcells are tested in clinical trials, it would be prudent to
D
define basic mechanisms in animal models. The initial P
analysis of isl1+ cells has been relatively extensive, and
the demonstration of calcium transients and cardiac ac-
tion potentials is encouraging, but a recent report indi-
cates that a population of small cells resident in skeletal
muscle can also be expanded in culture and differentiatednto cardiac myocytes with mature sarcomeres, calcium
ransients, cardiac action potentials, and β-adrenergic re-
ponsiveness (Winitsky et al., 2005). When delivered by
ail vein injection after acute myocardial infarction,
hese cells, called SPOC cells, home to the damaged
yocardium and differentiate into myocytes. The rela-
ionship between these cells and the apparently dis-
inct resident stem cell populations needs to be ex-
lored. Suggestions of multipotentiality require more
trict purification criteria and clonal assays. Resident
tem cells in other tissues are dependent upon appro-
riate local environments, or niches, to maintain viabil-
ty (Fuchs et al., 2004), but detailed information regard-
ng a cardiac resident stem cell niche is lacking.
espite the enticing therapeutic potential of cardiac re-
eneration, a host of important questions remain to be
nswered before rational approaches will allow for opti-
al clinical utility.
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